Gene therapy for brain tumors: gene therapy for malignant brain tumors using prodrug-sensitivity genes (series 4)
Tamiya, T.; Ohmoto, T.; Wei, M.X.; Breakfield, X.O.; Chiocca, E.A.
No Shinkei Geka. Neurological Surgery 22(12): 1099-1110
1994
ISSN/ISBN: 0301-2603 PMID: 7845504 Document Number: 424488
Document emailed within 1 workday
Related Documents
Nitta, T. 1994: Gene therapy for brain tumors: antitumor effects of introduction of antisense and tumor suppressor gene (series 2) No Shinkei Geka. Neurological Surgery 22(10): 903-909Okada, H. 1999: Neurosurgery and molecular biology: (series 10) gene therapy and biological therapy for brain tumors No Shinkei Geka. Neurological Surgery 27(1): 9-17
Kawamura, K.; Yu, L.; Tomizawa, M.; Shimozato, O.; Ma, G.; Li, Q.; Sato, A.; Yang, Y.; Suzuki, T.; Abdel-Aziz, N.Mohamed.; Tagawa, M. 2007: Transcriptional regulatory regions of the survivin gene activate an exogenous suicide gene in human tumors and enhance the sensitivity to a prodrug Anticancer Research 27(1a): 89-93
Mizuno, M.; Yoshida, J. 2001: Perspectives on postgenome medicine: Gene therapy for brain tumors Nihon Rinsho. Japanese Journal of Clinical Medicine 59(1): 76-80
Nakahara, N.; Yoshida, J. 2005: Gene therapy for brain tumors--present conditions and prospects Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(4): 458-462
Kostron, H. 1987: Therapy of malignant brain tumors Wiener Klinische Wochenschrift 99(11): 366-369
Kochi, M.; Ushio, Y. 1994: Targeting therapy for malignant brain tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(6): 738-742
Hirschberg, H.; Sørensen, D.R.; Angell-Petersen, E.; Peng, Q.; Tromberg, B.; Sun, C-Ho.; Spetalen, S.; Madsen, S. 2006: Repetitive photodynamic therapy of malignant brain tumors Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 25(1-2): 261-279
Nagai, M.; Arai, T. 1982: Interferon therapy for malignant brain tumors-present and future No Shinkei Geka. Neurological Surgery 10(5): 463-476
Marek, K. 1972: Trial of cytostatic therapy of malignant brain tumors in adults Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 110(1): 27-43
Juhl, H.; Czubayko, F.; Henne-Bruns, D. 1998: Ribozyme targeting as gene therapy method for treatment of malignant tumors Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 115: 1474-1477
Neve, R.L.; Geller, A.I. 1995: A defective herpes simplex virus vector system for gene delivery into the brain: comparison with alternative gene delivery systems and usefulness for gene therapy Clinical Neuroscience 3(5): 262-267
Grgić, M. 2000: Gene therapy of tumors of the head and neck: clinical use of the p53 tumor suppressor gene Lijecnicki Vjesnik 122(1-2): 14-16
Nagashima, T. 2005: Tumor suppressor gene in brain tumors Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 9): 44-48
Nomura, K.; Nagane, M.; Shibui, S. 1992: Chemo-sensitivity test for malignant brain tumors by DNA histogram, in vitro Nihon Rinsho. Japanese Journal of Clinical Medicine 50(10): 2374-2380
Takagaki, M.; Ono, K.; Oda, Y.; Kikuchi, H.; Nemoto, H.; Iwamoto, S.; Cai, J.; Yamamoto, Y. 1996: Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors Cancer Research 56(9): 2017-2020
Bunyaratavej, K.; Siwanuwatn, R.; Chantra, K.; Khaoroptham, S. 2010: Duration of symptoms in brain tumors: influencing factors and its value in predicting malignant tumors Journal of the Medical Association of Thailand 93(8): 903-910
Yamasaki, T.; Kikuchi, H.; Yamashita, J.; Kärre, K.; Ljunggren, H.G.; Klein, G. 1989: Molecular analysis of mouse major histocompatibility complex class I gene expression of tumors growing in the brain No Shinkei Geka. Neurological Surgery 17(3): 229-237
Rob, L.; Svoboda, B.; Robová, H.; Stankusová, H.; Cwiertka, K.; Neumannová, R.; Petera, J.; Koliba, P.; Kudela, M. 2004: Guideline for gynecological malignant tumors--primary complex therapy in operable stages of malignant tumors of uterus cervix Ceska Gynekologie 69(5): 376-383
Wicke, I.; Gansbacher, B. 1996: Using the thymidine kinase gene in therapy of solid tumors Der Internist 37(4): 369-373